Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Solinas Medical

Solinas Medical
2010 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$1.46M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of medical devices designed to improve patients' lives through innovation. The company's devices for cannulation purpose include a product called ReTAP™ Patch to prevent leakage during hemodialysis, enabling doctors to perform renal therapies with ease.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Diagnostic Equipment
Primary Office
  • 2918 Scott Boulevard
  • Santa Clara, CA 95054
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Solinas Medical’s full profile, request a free trial.

Solinas Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Jan-2017 $1.46M 00.000 Completed Product Development
4. Grant 19-Jan-2016 00000 00.000 Completed Product Development
3. Early Stage VC (Series A) 25-Feb-2014 00.000 00.000 000.00 Completed Product Development
2. Grant 09-Aug-2013 $500K Completed Startup
1. Grant 17-Nov-2011 $150K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Solinas Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
To view this company’s complete Cap Table, request access »

Solinas Medical Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0

Solinas Medical Executive Team (4)

Name Title Board
Seat
Contact
Info
James Hong Chief Executive Officer & Director
Eric Coblin Vice President, Operations & Quality Assurance
Michael Kolber Vice President of Regulatory Affairs

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »